Why?
They must halt to release price sensitive info, and that is definitely price sensitive ?
Its up to the company to decide when to release the info, and in the case of the info coming from a 3rd party like the FDA, the
company is not simply a messenger hitting the forward button.As a share holder i need to know what the company intends to do about the 3rd party information. If that takes a few days, it takes a few days. Clearly they would need to formulate and then articulate a plan that addresses the issues if there are any.
MSB POST FDA approval, page-78
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |